NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Mulrow CD, Chiquette E, Ferrer RL, et al. Management of Chronic Hypertension During Pregnancy. Rockville (MD): Agency for Healthcare Research and Quality (US); 2000 Aug. (Evidence Reports/Technology Assessments, No. 14.)
This publication is provided for historical reference only and the information may be out of date.
Efficacy Data and Randomized Controlled Trials
Treatment Search Strategy - MEDLINE
1 randomized controlled trial.pt.
2 randomized controlled trials/
3 random$.tw.
4 random allocation/
5 double-blind method/
6 single-blind method/
7 ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$)).tw.
8 exp controlled clinical trials/
9 controlled clinical trial.pt.
10 exp clinical trials/
11 clinical trial.pt.
12 (clin$ adj25 (control$ or trial$)).tw.
13 exp research design/
14 placebos/
15 placebo effect/
16 placebo$.tw.
17 or/1-16
18 exp pregnancy/
19 pregnan$.tw.
20 or/18-19
21 exp hypertension/
22 hypertens$.tw.
23 or/21-22
24 exp antihypertensive agents/
25 exp calcium channel blockers/
26 (calcium adj channel adj block$).tw.
27 exp vasodilator agents/
28 exp adrenergic antagonists/
29 (alpha adj block$).tw.
30 (beta adj block$).tw.
31 exp vascular capacitance/
32 exp vascular resistance/
33 exp angiotensin converting enzyme inhibitors/
34 ((angiotensin adj receptor$) and block$).tw.
35 (ace and inhibit$).tw.
36 methyldopa.sh,tw.
37 aspirin.sh,tw.
38 (acetysalicylic adj acid).sh,tw.
39 exp diuretics/
40 diuret$.tw.
41 or/24-40
42 bed rest/
43 ((bed adj rest) or bedrest).tw.
44 biofeedback.sh,tw.
45 exp relaxation techniques/
46 relax$.tw.
47 exp diet therapy/
48 (stress adj (reduc$ or manag$)).tw.
49 exp hydrotherapy/
50 exp alternative medicine/
51 exp exercise therapy/
52 exercise.tw.
53 smoking cessation/
54 smoking/
55 or/42-54
56 41 or 55
57 17 and 20 and 23 and 56
58 (animal not human).sh.
59 57 not 58
Treatment II Search Strategy - MEDLINE
1 randomized controlled trial.pt.
2 randomized controlled trials/
3 random$.tw.
4 random allocation/
5 double-blind method/
6 single-blind method/
7 ((singl$ or doubl$ or tripl$ or trebl$) adj25 (blind$ or mask$)).tw.
8 exp controlled clinical trials/
9 controlled clinical trial.pt.
10 exp clinical trials/
11 clinical trial.pt.
12 (clin$ adj25 (control$ or trial$)).tw.
13 exp research design/
14 placebos/
15 placebo effect/
16 placebo$.tw.
17 or/1-16
18 exp pregnancy/
19 pregnan$.tw.
20 or/18-19
21 exp hypertension/
22 hypertens$.tw.
23 or/21-22
24 calcium.sh,tw.
25 magnesium.sh,tw.
26 zinc.sh,tw.
27 rhubarb.sh,tw.
28 (sodium or salt).sh,tw.
29 fish oils.sh,tw.
30 (fish$ and oil$).tw.
31 or/24-30
32 17 and 20 and 23 and 31
33 (animal not human).sh,tw.
34 32 not 33
Treatment Search Strategy - EMBASE
1 randomized controlled trial/
2 random$.tw.
3 randomization/
4 double blind procedure/
5 single blind procedure/
6 ((singl$ or doubl$ or tripl$ or treble$) adj25 (blind$ or mask$)).tw.
7 exp controlled study/
8 exp clinical trial/
9 (clin$ adj25 (control$ or trial$)).tw.
10 exp methodology/
11 placebo/
12 (placebo$ adj effect$).tw.
13 placebo$.tw.
14 or/1-13
15 exp pregnancy/
16 pregnan$.tw.
17 or/15-16
18 exp hypertension/
19 hypertens$.tw.
20 or/18-19
21 exp antihypertensive agent/
22 exp calcium channel blocking agent/
23 (calcium adj channel adj block$).tw.
24 exp vasodilator agent/
25 exp adrenergic receptor blocking agent/
26 (alpha adj block$).tw.
27 (beta adj block$).tw.
28 (vascular adj capaci$).tw.
29 exp vascular resistance/
30 exp dipeptidyl carboxypeptidase inhibitor/
31 ((angiotensin adj receptor$) and block$).tw.
32 (ace adj inhib$).tw.
33 methyldopa/
34 acetylsalicylic acid/
35 aspirin$.tw,sh.
36 exp diuretic agent/
37 diuret$.tw.
38 or/21-37
39 bed rest/
40 ((bed adj rest) or bedrest).tw.
41 exp feedback system/
42 (leisure or meditation).tw,hw,sh.
43 relax$.tw.
44 exp diet therapy/
45 (stress adj (reduc$ or manag$)).tw.
46 exp hydrotherapy/
47 exp alternative medicine/
48 exp kinesiotherapy/
49 exercise$.tw.
50 smoking cessation/
51 cigarette smoking/
52 or/39-51
53 38 or 52
54 14 and 17 and 20 and 53
55 (animal not human).sh.
56 54 not 55
Treatment II Search Strategy - EMBASE
1 randomized controlled trial.pt.
2 randomized controlled trial/
3 raandom$.tw.
4 randomization/
5 double blind procedure/
6 single blind procedure/
7 ((singl$ or doubl$ or tripl$ or treble$) adj25 (blind$ or mask$)).tw.
8 exp controlled study/
9 controlled study.pt.
10 exp clinical trial/
11 clinical trial.pt.
12 (clin$ adj25 (control$ or trial$)).tw.
13 exp methodology/
14 placebo/
15 (placebo$ adj effect$).tw.
16 placebo$.tw.
17 or/1-16
18 exp pregnancy/
19 pregnan$.tw.
20 or/18-19
21 exp hypertension/
22 hypertens$.tw.
23 or/21-22
24 calcium.sh,tw.
25 magnesium.sh,tw.
26 zinc.sh,tw.
27 (sodium or salt).sh.tw.
28 thiazide.sh,tw.
29 fish oil.sh,tw.
30 (fish$ and oil$).tw.
31 or/24-30
32 17 and 20 and 23 and 31
33 limit human
Treatment Search Strategy - Cochrane Library
1 RANDOMIZED-CONTROLLED-TRIALS*:ME
2 RANDOM-ALLOCATION*:ME
3 ((RANDOM* next CONTROL*) next TRIAL*)
4 DOUBLE-BLIND-METHOD*:ME
5 SINGLE-BLIND-METHOD*:ME
6 TRIPLE-BLIND
7 (((((SINGL* or DOUBL*) or TRIPL*) or TREBL*) or MASK*) and BLIND)
8 CLINICAL-TRIALS*1:ME
9 (CONTROL* next TRIAL*)
10 ((CONTROL* next CLINIC*) next TRIAL*)
11 RESEARCH-DESIGN*1:ME
12 (RESEARCH next DESIGN*)
13 PLACEBO-EFFECT*:ME
14 (#1 or #2) or #3) or #4) or #5) or #6) or #7) or #8) or #9) or #10) or #11) or #12) or #13)
15 PREGNANCY*:ME
16 PREGNANCY-OUTCOME*:ME
17 PREGNANCY-COMPLICATIONS-CARDIOVASCULAR*:ME
18 PREGNANCY-COMPLICATIONS-HEMATOLOGIC*:ME
19 PREGNANCY-MULTIPLE*:ME
20 (PREGNANC* and MULTIPLE)
21 PREGNANCY-TRIMESTERS*1:ME
22 PREGNAN*
23 BODY-WEIGHT*1:ME
24 (#15 or #16) or #17) or #18) or #19) or #20) or #21) or #22) or #23)
25 HYPERTENSION*1:ME
26 HYPERTENS*
27 (#25 or #26)
28 ANTIHYPERTENSIVE-AGENTS*:ME
29 (ANTIHYPERTENS* and AGENT*)
30 (ANTIHYPERTENS* and DRUG*)
31 (CALCIUM and (CHANNEL and BLOCKERS))
32 CALCIUM-CHANNEL-BLOCKERS*:ME
33 VASODILATOR-AGENTS*:ME
34 (VASODILATOR and (AGENT* or DRUG*))
35 ADRENERGIC-ANTAGONISTS*1:ME
36 VASCULAR-CAPACITANCE*:ME
37 (VASCULAR next CAPACIT*)
38 VASCULAR-RESISTANCE*1:ME
39 ANGIOTENSIN-CONVERTING-ENZYME-INHIBITORS*:ME
40 (((ANGIOTENSIN next CONVERT*) and ENZYME*) and INHIBIT*)
41 DIURETICS*1:ME
42 DIURET*
43 (ALPHA next BLOCK*)
44 (BETA next BLOCK*)
45 (ACE next INHIBIT*)
46 ASPIRIN*:ME
47 METHYLDOPA:ME
48 MAGNESIUM
49 CALCIUM
50 SODIUM OR SALT
51 ZINC
52 RHUBARB
53 FISH-OILS*1:ME
54 (FISH near OIL*)
55 (#28 or #29) or #30) or #31) or #32) or #33) or #34) or #35) or #36) or #37) or #38) or #39) or #40) or #41) or #42) or #43) or #44) or #45) or #46) or #47) or #48) or #49) or #50) or #51) or #52) or #53) or #54)
56 BED-REST*:ME
57 (BED next REST)
58 BEDREST
59 (BIOFEEDBACK-( and (PSYCHOLOGY) and *:ME))
60 BIOFEEDBACK
61 RELAXATION-TECHNIQUES*1:ME
62 RELAX*
63 DIET-THERAPY*1:ME
64 (DIET and THERAP*)
65 (STRESS and (MANAG* or REDUC*))
66 HYDROTHERAPY:ME
67 (HYDRO* and THERAP)
68 ALTERNATIVE-MEDICINE*1:ME
69 EXERCISE-THERAPY*1:ME
70 MASSAGE
71 EXERCIS*
72 SMOKING-CESSATION
73 SMOKING*1:ME
74 MEDITAT*
75 (#55) or #56) or #57) or #58) or #59) or #60) or #61) or #62) or #63) or #64) or #65) or #66) or #67) or #68) or #69) or #70) or #71) or #72) or #74)
76 (#55 or #75)
77 (((#14 and #24) and #27) and #75)
Treatment Search Strategy - CINAHL
1 random assignment.sh.
2 random.tw.
3 (random adj control$ adj trial$).tw.
4 (random adj allocat$).tw.
5 double-blind studies/
6 single-blind studies/
7 ((singl$ or doubl$ or tripl$ or treb$) adj (blind$ or mask$)).tw.
8 exp clinical trials/
9 (clin$ adj control$ adj trial$).tw.
10 clinical trial.pt.
11 systematic review.pt.
12 (clin$ adj trial$).tw.
13 exp study design/
14 placebos.sh.
15 (placebo$ and effect$).tw.
16 placebo$.tw.
17 or/1-16
18 exp pregnancy/
19 pregnan$.tw.
20 or/18-19
21 exp hypertension/
22 hypertens$.tw.
23 or/21-22
24 exp antihypertensive agents/
25 exp calcium channel blockers/
26 (calcium adj channel adj block$).tw.
27 exp vasodilator agents/
28 exp adrenergic antagonists/
29 (alpha adj block$).tw.
30 (beta adj block$).tw.
31 (vascular adj capac$).tw.
32 exp vascular resistance/
33 exp angiotensin converting enzyme inhibitors/
34 ((angiotensin adj receptor$) and block$).tw.
35 (ace and inhibit$).tw.
36 methyldopa.sh,tw.
37 aspirin/
38 (acetysalicylic adj acid).sh,tw.
39 exp diuretics/
40 diuret$.tw.
41 or/24-40
42 bed rest/
43 ((bed adj rest) or bedrest).tw.
44 biofeedback/
45 exp relaxation techniques/
46 relax$.tw.
47 exp diet therapy/
48 stress management.sh. or ((stress adj reduc$) or manag$).tw.
49 exp hydrotherapy/
50 exp alternative medicine/
51 exp exercise therapy/
52 exercise.tw.
53 smoking/
54 (smok$ and (cessat$ or quit$ or stop$)).tw.
55 or/42-54
56 41 or 55
57 17 and 20 and 23 and 56
58 (animal not human).sh.
59 57 not 58
Treatment II Search Streategy - CINAHL
1 random assignment.sh.
2 random.tw.
3 (random adj control$ adj trial$).tw.
4 (random adj allocat$).tw.
5 double-blind studies/
6 single-blind studies/
7 ((singl$ or doubl$ or tripl$ or treb$) adj (blind$ or mask$)).tw
8 exp clinical trials/
9 (clin$ adj control$ adj trial$).tw.
10 clinical trial.pt.
11 systematic review.pt.
12 (clin$ adj trial$).tw.
13 exp study design/
14 placebos.sh.
15 (placebo$ and effect$).tw.
16 placebo$.tw.
17 or/1-16
18 exp pregnancy/
19 pregnan$.tw.
20 or/18-19
21 exp hypertension/
22 hypertens$.tw.
23 or/21-22
24 calcium.sh,tw.
25 magnesium.sh,tw.
26 zinc.sh,tw.
27 (sodium or salt).sh,tw.
28 thiazide.sh,tw.
29 fish oil.sh,tw.
30 (fish$ and oil$).tw.
31 or/23-30
32 17 and 20 and 23 and 31
33 limit 32 to human
Data About Harms
Adverse Effects Search Strategy - MEDLINE
1 atenolol/
2 labetalol/
3 pindolol/
4 methyldopa/
5 captopril/
6 enalapril/
7 quinapril/
8 fosinopril/
9 lisinopril/
10 benazepril/
11 ramipril/
12 trandolapril/
13 losartan/
14 valsartan/
15 eprosartan/
16 irbesartan/
17 furosemide/
18 hydrochlorothiazide/
19 hydralazine/
20 clonidine/
21 nifedipine/
22 amlodipine/
23 diltiazem/
24 verapamil/
25 or/1-24
26 atenolol.tw.
27 labetalol.tw.
28 pindolol.tw.
29 methyldopa.tw.
30 captopril.tw.
31 enalapril.tw.
32 quinapril.tw.
33 fosinopril.tw.
34 lisinopril.tw.
35 benazepril.tw.
36 ramipril.tw.
37 trandolapril.tw.
38 losartan.tw.
39 valsartan.tw.
40 eprosartan.tw.
41 irbesartan.tw.
42 furosemide.tw.
43 hydrochlorothiazide.tw.
44 hydralazine.tw.
45 clonidine.tw.
46 nifedipine.tw.
47 amlodipine.tw.
48 diltiazem.tw.
49 verapamil.tw.
50 or/26-49
51 or/25-50
52 exp pregnancy/
53 exp pregnancy complications/
54 pregnan$.tw.
55 exp abnormalities/
56 exp fetal development/
57 exp fetal diseases/
58 or/52-57
59 51 and 58
60 (AE or CO or PO).fs.
61 Case report/
62 60 or 61
63 and human/
64 59 and 63
Data About Blood Pressure Risks and Optimum Treatment Levels
Blood Pressure Level: Risk Search Strategy - MEDLINE
1 hypertension.sh.
2 hypertens$.tw.
3 exp blood pressure
4 or/1-3
5 exp pregnancy
6 pregnan$.tw.
7 or/5-6
8 4 and 7
9 exp cohort studies
10 cohort$.tw.
11 prognosis/
12 case-control studies/
13 or/9-12
14 8 and 13
15 limit 14 to human
16 15 not letter.pt,sh,ti.
17 16 not editorial.pt,sh,ti.
18 167 not case report.pt,sh,ti.
Data About Benefits and Harms of Special Fetal Monitoring Techniques
Monitoring Search Strategy - CINAHL
1 ((randomzed adj control$) and trial$).tw.
2 controlled clinical trial.pt.
3 systematic review.pt,sh
4 (random and allocat$).tw.
5 single-blind studies/
6 double-blind studies/
7 or/1-6
8 clinical trial.pt. ((randomized adj control$) and trial).tw.
9 exp clinical trials/
10 (clin$ adj trial$).tw.
11 ((singl$ or doubl$ or tripl$ or trebl$) and (blind$ or mask$)).tw.
12 placebos/
13 placebo$.tw.
14 random$.tw.
15 exp study design/
16 or/8-15
17 comparative studies/
18 exp evaluation studies/
19 exp prospective studies/
20 follow-up.tw.
21 (control$ or prospectiv$ or volunteer$).tw.
22 or/17-21
23 animal/ not (human/ and animal/)
24 7 or 16 or 22
25 24 not 23
26 exp ultrasonography, prenatal/
27 exp fetal monitoring/
28 exp fetal movement/
29 exp heart rate, fetal/
30 exp prenatal diagnosis/
31 or/26-30
32 *biometry/
33 exp ultrasonography, doppler/
34 exp pregnancy/
35 32 or 33
36 34 and 35
37 31 or 36
38 (non adj stress).tw.
39 nonstress.tw.
40 (fetal adj30 surveillance).tw.
41 (antenatal adj30 surveillance).tw.
42 (fetal adj30 screen$).tw
43 (antenatal adj30 screen).tw.
44 (prenatal adj30 screen$).tw.
45 (fetal adj30 monitor$).tw.
46 (fetal adj30 movement$).tw.
47 fetal biophysical profile/
48 (amniotic adj fluid adj index).tw.
49 (contraction adj stress adj test$).tw.
50 (fundal adj height).tw
51 or/38-50
52 (doppler and velocimetry).tw.
53 52 and 34
54 51 or 53
55 54 or 37
56 exp hypertension/
57 hypertens$.
58 56 or 57
59 55 and 58
Monitoring Search Strategy - EMBASE
1 randomized controlled trial/
2 randomization/
3 single-blind procedure/
4 double-blind procedure/
5 or/1-4
6 exp clinical trial/
7 (clin$ adj25 trial$).tw.
8 ((singl$ or doubl$ or tripl$ or trebl$) and (blind$ or mask$)).tw.
9 placebos/
10 placebo$.tw.
11 random$.tw.
12 exp methodology/
13 or/6-12
14 comparison/
15 exp evaluation and follow up/
16 ((follow up) or follow-up).tw.
17 prospective study/
18 (control$ or prospectiv$ or volunteer$).tw.
19 or/14-18
20 5 or 13 or 19
21 limit 20 to humans
22 ultrasonography/
23 exp fetus monitoring/
24 exp fetal movement/
25 exp fetus heart rate/
26 exp prenatal diagnosis/
27 exp prenatal screening/
28 (ultrasonograph$ and doppler).tw.
29 (non adj stress).tw.
30 nonstress.tw.
31 (fetal adj surveillance).tw.
32 (antenatal adj surveillance).tw.
33 (fetal adj screen$).tw
34 (antenatal adj screen).tw.
35 (prenatal adj screen$).tw.
36 (velocity waveform$).tw.
37 monitoring method/
38 (biophysical adj profil$).tw.
39 (amniotic adj fluid adj index).tw.
40 (contraction adj stress adj test$).tw.
41 (fundal adj height).tw
42 (doppler and velocimetry).tw.
43 or/22-42
44 pregnancy/ or pregnan$.tw.
45 21 and 43 and 44
46 limit 45 to human
Monitoring Search Strategy - HEALTHSTAR
1 randomized controlled trial.ti,kw,ab,pt.
2 randomized controlled trials.ti,kw,ab,pt.
3 controlled clinical trial .ti,kw,ab,pt.
4 random allocation/
5 single-blind method/
6 double-blind method/
7 or/1-6
8 clinical trial.ti,kw,ab,pt.
9 clinical trials.ti,kw,ab.
10 (clin$ and trial$).ti,kw,ab.
11 placebos/
12 placebo$. ti,kw,ab.
13 random$. ti,kw,ab.
14 exp research design/
15 ((singl$ or doubl$ or tripl$ or treble$) and (blind$ or mask$). ti,kw,ab.
16 or/8-15
17 comparative study/
18 evaluation studies/
19 (follow up or follow-up or followup). ti,kw,ab.
20 prospective studies/
21 (control$ or prospectiv$ or volunteer$). ti,kw,ab.
22 or/17-21
23 7 or 16 or 22
24 limit 23 to human
25 ultrasonography/ or ultrasound. ti,kw,ab.
26 fetal monitoring/
27 (fetal and move$). ti,kw,ab.
28 heart rate, fetal. ti,kw,ab.
29 ((prenatal or fetal) and diagnos$). ti,kw,ab.
30 ((ultrasonog$ or ultrasound) and doppler). ti,kw,ab.
31 nonstress. ti,kw,ab.
32 ((non adj stress) or non-stress). ti,kw,ab.
33 (fetal and surveillance). ti,kw,ab.
34 (antenatal and surveillance). ti,kw,ab.
35 (fetal and screen$). ti,kw,ab.
36 (prenatal and screen$). ti,kw,ab.
37 (velocity and waveform$). ti,kw,ab.
38 exp monitoring, physiologic/
39 (biophysical and profil$). ti,kw,ab.
40 (amniotic adj fluid) and index. ti,kw,ab.
41 (contract$ and stress). ti,kw,ab.
42 (fundal adj height). ti,kw,ab.
43 (doppler and veloc). ti,kw,ab.
44 or/25-43
45 (pregnancy/ or pregnan$). ti,kw,ab.
46 (high-risk or (high adj risk). ti,kw,ab.
47 exp hypertension/ or (hypertensive or hypertens$). ti,kw,ab.
48 46 or 47
49 45 and 48
50 24 and 44 and 49
51 limit 50 to human
52 limit 51 to nonmedline
Monitoring Search Strategy - MEDLINE
1 randomized controlled trial.pt.
2 randomized controlled trials/
3 controlled clinical trial.pt.
4 random allocation/
5 single-blind method/
6 double-blind method/
7 or/1-6
8 clinical trial.pt.
9 exp clinical trials/
10 (clin$ adj trial$).tw.
11 ((singl$ or doubl$ or tripl$ or trebl$) and (blind$ or mask$)).tw.
12 placebos/
13 placebo$.tw.
14 random$.tw.
15 exp research design/
16 or/8-15
17 comparative study/
18 exp evaluation studies/
19 follow up studies/
20 prospective studies/
21 (control$ or prospectiv$ or volunteer$).tw.
22 or/17-21
23 animal/ not (human/ and animal/)
24 7 or 16 or 22
25 24 not 23
26 exp ultrasonography, prenatal/
27 exp fetal monitoring/
28 exp fetal movement/
29 exp heart rate, fetal/
30 exp prenatal diagnosis/
31 or/26-30
32 *biometry/
33 exp ultrasonography, doppler/
34 exp pregnancy/
35 32 or 33
36 34 and 35
37 31 or 36
38 (non adj stress).tw.
39 nonstress.tw.
40 (fetal adj30 surveillance).tw.
41 (antenatal adj30 surveillance).tw.
42 (fetal adj30 screen$).tw
43 (antenatal adj30 screen).tw.
44 (prenatal adj30 screen$).tw.
45 (fetal adj30 monitor$).tw.
46 (fetal adj30 movement$).tw.
47 (biophysical adj profil$). tw.
48 (amniotic adj fluid adj index).tw.
49 (contraction adj stress adj test$).tw.
50 (fundal adj height).tw
51 or/38-50
52 (doppler and velocimetry).tw.
53 52 and 34
54 51 or 53
55 54 or 37
56 55 and 25
57 limit 56 to human
Monitoring Search Strategy - Biological Abstracts
1 randomized controlled trial.ti,kw,ab.
2 randomized controlled trials.ti,kw,ab,cc.
3 random allocation.ti,kw,ab,cc.
4 controlled clinical trial.ti,kw,ab,cc.
5 (single adj blind).ti,kw,ab,cc.
6 (double adj blind).ti,kw,ab,cc.
7 or/1-6
8 clinical trial.ti,kw,ab,cc.
9 clinical trials.ti,kw,ab,cc.
10 (clin$ and trial$).ti,kw,ab,cc.
11 placebos. ti,kw,ab,cc.
12 placebo$. ti,kw,ab,cc.
13 random$. ti,kw,ab,cc.
14 research. ti,kw,ab,cc.
15 ((singl$ or doubl$ or tripl$ or trebl$) and (blind or mask$). ti,kw,ab,cc.
16 or/8-15
17 (comparative and stud$). ti,kw,ab,cc.
18 (evaluative and stud$). ti,kw,ab,cc.
19 ((follow-up or follow up or followup) and stud$). ti,kw,ab,cc.
20 (prospective and stud$). ti,kw,ab,cc.
21 (control$ or prospectiv$ or volunteer). ti,kw,ab,cc.
22 or/17-21
23 7 or 16 or 22
24 limit 23 to humans
25 (ultrasonography or ultrasound). ti,kw,ab,cc.
26 (fetal and monitor). ti,kw,ab,cc.
27 (fetal and movement$). ti,kw,ab,cc.
28 (fetal and heart and rate). ti,kw,ab,cc.
29 ((prenatal or fetal) and diagnos$). ti,kw,ab,cc.
30 (ultrasonogr$ or ultrasound$). ti,kw,ab,cc.
31 nonstress. ti,kw,ab,cc.
32 (non adj stress). ti,kw,ab,cc.
33 (fetal and surveillance). ti,kw,ab,cc.
34 (antenatal and surveillance). ti,kw,ab,cc.
35 (fetal and screen$). ti,kw,ab,cc.
36 (prenatal and screen). ti,kw,ab,cc.
37 (velicity and waveform$). ti,kw,ab,cc.
38 monitoring method. ti,kw,ab,cc.
39 (biophysical and profil$). ti,kw,ab,cc.
40 (amniotic and fluid and index). ti,kw,ab,cc.
41 (contract$ and stress$. ti,kw,ab,cc.
42 (fundal adj height). ti,kw,ab,cc.
43 (doppler and veloc$). ti,kw,ab,cc.
44 or/25-43
45 (pregnancy or pregnan$). ti,kw,ab,cc.
46 ((high risk) or (high-risk). ti,kw,ab,cc.
47 (hypertension or hypertens$). ti,kw,ab,cc.
48 46 or 47
49 45 and 48
50 24 and 44 and 49
51 limit 50 to humans
Monitoring Search Strategy - FEDRIP (Federal Research in Progress)
1 s Randomized controlled trial?
2 s Controlled clinical trial?
3 s Random allocation
4 s Single(w)blind
5 s Double(w)blind
6 s Clinical trial?
7 s Clin? and trial?
8 s Placebo?
9 s Random?
10 s Research
11 s Or/1-10
12 s Singl? Or doubl? Or tripl? Or trebl?
13 s Blind or mask?
14 s s12 and s13
15 s s11 or s14
16 s comparative and stud?
17 s Evaluative and stud?
18 s (Followup or follow(w)up or follow up) and stud?
19 s Prospective and stud?
20 s Control? Or prospectiv? Or volunteer?
21 s Or/16-21
22 s s11 or s15 or s21
23 s ultrasonogr? or ultrasound?
24 s fetal and monitor?
25 fetal and movement?
26 s fetal(w)heart(w)rate
27 s prenatal and diagnos?
28 s fetal and diagnos?
29 s nonstress
30 s fetal and surveillanc?
31 s antenatal and surveillanc?
32 s fetal and screen?
33 s prenatal and screen?
34 s velocity and waveform
35 s monitoring(w)method
36 s biophysical and profil?
37 s amniotic(w)fluid(w)index
38 s contract? and stress?
39 s fundal(w)height
40 s doppler and veloc?
41 s or/23-40
42 s pregnan?
43 s s41 and s42
44 s s22 or s42 and s43
45 s s44/human
46 s s45and py=1988:1992
- Appendix A: Search strategies - Management of Chronic Hypertension During Pregna...Appendix A: Search strategies - Management of Chronic Hypertension During Pregnancy
Your browsing activity is empty.
Activity recording is turned off.
See more...